Ultimele actualizari :
27/11/2024
Citostatic   Eribulin mesylate  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf
   Formula chimica  

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Elefix Argentina
Halaven Argentina, Belgia, Brazilia, Canada, Chilli, Danemarca, Elvetia, Finlanda, Franta, Germania, Irlanda, Islanda, Italia, Japonia, Luxemburg, Malaezia, Marea Britanie, Mexic, Norvegia, Peru, Romania, Slovenia, Spania, Suedia, Ungaria
Bibliografie   Injectabil   Bibliografie : Eribulin mesylate  
tip publicare
3250 Laborator Eribulin (Halaven®) - Summary of Product Characteristics.
Eisai Ltd 2011
3331 ziar Poujol S, Dell'ova M, Bekhtari K, Bressolle F, Pinguet F.
Stability of the ready-to-use solutions of eribulin for intravenous infusion.
Ann Pharm Fr 2012 ; 70, 5: 249-255.
3707 ziar Spindeldreier K, Thiesen J, Lipp H.P, Krämer I.
Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
J Oncol Pharm Practice 2014 ; 20: 183-189

  Mentions Légales